These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13693095)

  • 1. Primaquine sensitivity of erythrocytes.
    CHILDS B
    Arch Intern Med; 1961 Feb; 107():151-3. PubMed ID: 13693095
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity to hemolytic drugs: an inborn error of metabolism of the red cell.
    Beutler E
    Am J Clin Nutr; 1961; 9():700-4. PubMed ID: 13868719
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations on the haemolytic effect of primaquine in 100 Ghanaian children.
    CHARLES LJ
    Ann Trop Med Parasitol; 1960 Dec; 54():460-70. PubMed ID: 13692485
    [No Abstract]   [Full Text] [Related]  

  • 4. The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes.
    BEUTLER E; DERN RJ; ALVING AS
    J Lab Clin Med; 1954 Aug; 44(2):177-84. PubMed ID: 13184225
    [No Abstract]   [Full Text] [Related]  

  • 5. Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine.
    Bowman ZS; Morrow JD; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2005 Aug; 314(2):838-45. PubMed ID: 15840764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DRUG-INDUCED hemolytic anemia.
    J Am Med Assoc; 1959 Oct; 171():894-5. PubMed ID: 13857343
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.
    KELLERMEYER RW; TARLOV AR; BREWER GJ; CARSON PE; ALVING AS
    JAMA; 1962 May; 180():388-94. PubMed ID: 14454972
    [No Abstract]   [Full Text] [Related]  

  • 8. HEMOLYTIC EFFECT OF PRIMAQUINE. XVI. GLYOXALASE ACTIVITY OF PRIMAQUINE-SENSITIVE AND NORMAL ERYTHROCYTES.
    BREWER GJ; POWELL RD; TARLOV AR; ALVING AS
    J Lab Clin Med; 1964 Jan; 63():106-21. PubMed ID: 14102892
    [No Abstract]   [Full Text] [Related]  

  • 9. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
    Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
    J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The existence of the glucose-6-phosphate dehydrogenase deficiency trait in Nigeria and its clinical implications.
    GILLES HM; TAYLOR BG
    Ann Trop Med Parasitol; 1961 Apr; 55():64-9. PubMed ID: 13705322
    [No Abstract]   [Full Text] [Related]  

  • 11. The hemolytic effect of primaquine. XIV. Pentose metabolism in primaquine-sensitive erythrocytes.
    KELLERMEYER RW; CARSON PE; SCHRIER SL; TARLOV AR; ALVING AS
    J Lab Clin Med; 1961 Nov; 58():715-24. PubMed ID: 14454971
    [No Abstract]   [Full Text] [Related]  

  • 12. The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character.
    DERN RJ; BEUTLER E; ALVING AS
    J Lab Clin Med; 1954 Aug; 44(2):171-6. PubMed ID: 13184224
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and genetic aspects of primaquine-sensitive hemolytic anemia.
    ALVING AS; KELLERMEYER RW; TARLOV A; SCHRIER S; CARSON PE
    Ann Intern Med; 1958 Aug; 49(2):240-8. PubMed ID: 13571815
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemolysis and primaquine treatment. Preliminary report].
    Menéndez Capote R; Díaz Pérez L; Luzardo Suárez C
    Rev Cubana Med Trop; 1997; 49(2):136-8. PubMed ID: 9685977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [METHEMOGLOBINEMIA, HEMOLYSIS AND FORMATION OF HEINZ BODIES IN THE ERYTHROCYTES].
    PALEK J
    Lek Veda Zahr; 1964 Jan; 1():1-10. PubMed ID: 14130762
    [No Abstract]   [Full Text] [Related]  

  • 16. The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis.
    BREWER GJ; TARLOV AR; ALVING AS
    JAMA; 1962 May; 180():386-8. PubMed ID: 13872968
    [No Abstract]   [Full Text] [Related]  

  • 17. METHEMOGLOBINEMIA AND HEINZ BODY HEMOLYTIC ANEMIA DUE TO PHENAZOPYRIDINE HYDROCHLORIDE.
    GREENBERG MS; WONG H
    N Engl J Med; 1964 Aug; 271():431-5. PubMed ID: 14171812
    [No Abstract]   [Full Text] [Related]  

  • 18. Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes.
    Bowman ZS; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2005 Dec; 315(3):980-6. PubMed ID: 16099929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes.
    SCHRIER SL; KELLERMEYER RW; CARSON PE; ICKES CE; ALVING AS
    J Lab Clin Med; 1959 Aug; 54():232-40. PubMed ID: 14443591
    [No Abstract]   [Full Text] [Related]  

  • 20. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
    Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.